Aura Biosciences Inc. Common Stock (AURA)
Stock · NASDAQ · Health Care
$7.4as of 8/28/2026
Price chart
Open in TradingViewActive signals
No technical signal is currently active for this symbol.
Support level
$6.96
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Fundamentals
- Market cap
- $728.19M
- P/E (trailing)
- —
- P/E (forward)
- —
- EPS (trailing)
- —
- Dividend yield
- —
- Beta
- —
- Avg. volume
- —
Aura Biosciences Inc. Common Stock Competitors
Chosen by industry and closest market cap.
- AURAAura Biosciences Inc. Common Stock$7.4▼ 3.90%Market cap $728.19MP/E —
- SLDBSolid Biosciences Inc. Common Stock$9.78▼ 3.46%Market cap $789.57MP/E —$3.79$11.45
- AGMBAgomAb Therapeutics NV American Depositary Shares$13.17▼ 4.84%Market cap $665.83MP/E —$8.75$17.82
- ALLOAllogene Therapeutics Inc. Common Stock$2.01▼ 3.83%Market cap $635.08MP/E —$1.04$4.46
- SANASana Biotechnology Inc. Common Stock$3.93▼ 3.91%Market cap $884.97MP/E —$2.61$6.55
- DNAGinkgo Bioworks Holdings Inc. Class A Common Stock$6.98▼ 3.93%Market cap $555.49MP/E —$5.37$17.58
- FDMT4D Molecular Therapeutics Inc. Common Stock$14.65▼ 1.74%Market cap $527.47MP/E —$5.97$16.93
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| AURA Aura Biosciences Inc. Common Stock | $728.19M | — | $7.4 | ▼ 3.90% | |
| SLDB Solid Biosciences Inc. Common Stock | $789.57M | — | $9.78 | ▼ 3.46% | $3.79$11.45 |
| AGMB AgomAb Therapeutics NV American Depositary Shares | $665.83M | — | $13.17 | ▼ 4.84% | $8.75$17.82 |
| ALLO Allogene Therapeutics Inc. Common Stock | $635.08M | — | $2.01 | ▼ 3.83% | $1.04$4.46 |
| SANA Sana Biotechnology Inc. Common Stock | $884.97M | — | $3.93 | ▼ 3.91% | $2.61$6.55 |
| DNA Ginkgo Bioworks Holdings Inc. Class A Common Stock | $555.49M | — | $6.98 | ▼ 3.93% | $5.37$17.58 |
| FDMT 4D Molecular Therapeutics Inc. Common Stock | $527.47M | — | $14.65 | ▼ 1.74% | $5.97$16.93 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Aura Biosciences: Ocular Oncology Firm Under New Management Has Shot At ApprovalSeekingAlpha · 8/12/2026
- Aura Biosciences May Offer Securities Up To $500M Aggregate; May Sell Up To $200M Common Stock Under Sales Agreement With JefferiesBenzinga · 8/11/2026
- HC Wainwright & Co. Maintains Buy on Aura Biosciences, Lowers Price Target to $18Benzinga · 8/11/2026
- Aura Biosciences Q2 EPS $(0.48) Misses $(0.38) EstimateBenzinga · 8/11/2026
Insider Activity
Insider Actions →Acquired
3.61M
Disposed
12.8K
- Jeremy Bender · July 7, 2026 · Grant60.0K
- Jeremy Bender · July 7, 2026 · Grant30.0K
- Conor Kilroy · July 1, 2026 · Grant14.9K
- Anthony S. Gibney · June 16, 2026 · Sale12.8K @ $6.42
- Teresa Marie Bitetti · June 11, 2026 · Grant30.0K
- Teresa Marie Bitetti · June 11, 2026 · Grant15.0K
- Sapna Srivastava · June 11, 2026 · Grant30.0K
- Sapna Srivastava · June 11, 2026 · Grant15.0K
- David Michael Johnson · June 11, 2026 · Grant30.0K
- David Michael Johnson · June 11, 2026 · Grant15.0K
- Antony C. Mattessich · June 11, 2026 · Grant30.0K
- Antony C. Mattessich · June 11, 2026 · Grant15.0K
- Natalie C. Holles · May 19, 2026 · Grant2.17M
- Natalie C. Holles · May 19, 2026 · Grant553.8K
- Natalie C. Holles · May 19, 2026 · Grant600.1K
Institutional Ownership
March 31, 2026
- Total shares held
- 50.35M
- Total value held
- $334.03M
- Institutional holders
- 121
Top holders this quarter
- Unknown6.92M
- Unknown5.10M
- Unknown4.88M
- Unknown4.62M
- Unknown4.37M
- Unknown3.59M
- Unknown3.04M
- Unknown2.24M
- Unknown2.12M
- Unknown2.07M
See the full, filterable feed with live charts on the MarketWall dashboard.